Yuka Nakamura, Hiroshi Watanabe, Teruya Nakamura, Mami Chirifu, Kana Ishiodori, Tadashi Imafuku, Hitoshi Maeda, Yoshihiro Kobashigawa, Hiroshi Morioka, Toru Maruyama. Contribution of Phe112, Ser114, and Tyr115 to Drug-Binding Selectivity in the A Variant of α1-Acid Glycoprotein. Molecular Pharmaceutics. 2024
Teruya Nakamura*, Chiaki Ohyama, Madoka Sakamoto, Tsugumasa Toma, Hiroshi Tateishi, Mihoko Matsuo, Mami Chirifu, Shinji Ikemizu, Hiroshi Morioka, Mikako Fujita, et al. TIFAB regulates the TIFA-TRAF6 signaling pathway involved in innate immunity by forming a heterodimer complex with TIFA. Proceedings of the National Academy of Sciences. 2024. 121. 11
Kentaro Oniki, Kayoko Ohura, Megumi Endo, Daniel Akatwijuka, Erika Matsumoto, Teruya Nakamura, Yasuhiro Ogata, Minoru Yoshida, Mariko Harada-Shiba, Junji Saruwatari, et al. The Association of the Cholesterol Efflux Capacity with the Paraoxonase 1 Q192R Genotype and the Paraoxonase Activity. Journal of Atherosclerosis and Thrombosis. 2024
Kengo Yasuda, Hitoshi Maeda, Ryo Kinoshita, Yuki Minayoshi, Yuki Mizuta, Yuka Nakamura, Shuhei Imoto, Koji Nishi, Keishi Yamasaki, Mina Sakuragi, et al. Encapsulation of an Antioxidant in Redox-Sensitive Self-Assembled Albumin Nanoparticles for the Treatment of Hepatitis. ACS Nano. 2023
Kosei Utatsu, Keiichi Motoyama, Teruya Nakamura, Risako Onodera, Taishi Higashi. Tannic acid-based sustained-release system for protein drugs. International Journal of Pharmaceutics. 2023. 123229-123229
Teruya Nakamura. Time-resolved X-ray crystallography of enzymatic reaction that degrades a mutagenic nucleotide. SPring-8/SACLA Research Frontiers 2022. 2023. 28-29